公式タイトルと情報はIP Exchange PlusとPremiumのユーザーのみが利用可能です。
特許 権利維持 Monobodies, also known as Adnectins, are genetically engineered proteins that are able to bind to antigens. Despite their name, they are not parts of antibodies, which makes them a type of antibody mimetic. They are being developed by Adnexus, a biotechnology company which has been part of Bristol-Myers Squibb since 2007.
追加情報の詳細を見るにはIP Exchange PlusまたはIP Exchange Premiumアカウントにアップグレードする必要があります
